BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
PRKCA
,
T cell receptor signaling pathway
,
Influenza
,
Kidney
,
Hematopoietic cell
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
methyl- levodopa hydrochloride
Summary
General Info
Curated Studies
Most Correlated Studies
Broad Connectivity Map (CMAP 2.0) compound database
Explore Curated Studies Results
Literature
Most Relevant Literature
Experimental study of antiparkinsonian action of the harmine hydrochloride original compound.
Pharmacokinetic evaluation of formulated levodopa methyl ester nasal delivery systems.
Pharmacological modulation of glutamate transmission in a rat model of L-DOPA-induced dyskinesia: ef…
Kinetic characterization of the oxidation of catecolamines and related compounds by laccase.
Interaction between nicotinic and dopaminergic therapies on cognition in a chronic Parkinson model.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Therapeutic Potential for Intranasal Levodopa in Parkinson's Disease -Off Reversal
Clinical Trial of Apomorphine Subcutaneous Infusion in Patients With Advanced Parkinson's Disease
Vitamin B6, B12, Folic Acid and Exercise in Parkinson's Disease
Study on the Safety, Tolerance and Pharmacokinetics of Phenlarmide Tablets
Randomized Single-blind Placebo Controlled Comparative Trial of Pramipexole and Bromocriptine in Par…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ